Status:

RECRUITING

Improving Independent Multi-joint Arm Control After Stroke

Lead Sponsor:

University of Houston

Collaborating Sponsors:

UT Health Houston

Korea Advanced Institute of Science and Technology

Conditions:

Stroke

Eligibility:

All Genders

40-75 years

Phase:

NA

Brief Summary

The purposes of this study include: 1. \- To identify whether features of aberrant intermuscular coordination patterns can be used to predict motor impairment after stroke. 2. \- To test whether musc...

Detailed Description

Stroke is a leading cause of long-term disability in the United States. Of the more than 700,000 Americans who experience a stroke each year, two-thirds survive. 69% of patients who were admitted to a...

Eligibility Criteria

Inclusion

  • Inclusion criteria for aged matched healthy group
  • Male or female whose age range between 40 and 75
  • no known neurological injuries
  • Exclusion criteria for aged matched healthy group
  • have an orthopedic disorder involving upper limbs;
  • have a history of any neurologic disease;
  • have any history of epilepsy of the potential participants and/or their family members;
  • are unable to consent;
  • are pregnant.
  • Inclusion criteria for stroke group
  • male or female hemiparetic chronic stroke survivors;
  • age ranging between 40-75 year;
  • with single unilateral ischemic or hemorrhagic middle cerebral artery stroke;
  • neurologically stable for \>6 months;
  • have an expectation that current medication will be maintained without changes for at least 3 months. Stable use of anti-spasticity medication (e.g., baclofen, diazepam, tizanidine) is accepted;
  • without severe spasticity (Modified Ashworth (MA) \<4);
  • have not received botulinum toxin on the impaired arm within 3 months.
  • Exclusion criteria for stroke group
  • have an orthopedic disorder involving upper limbs;
  • cognitive impairment sufficient to interfere with informed consent or successful completion of the protocol (Montreal Cognitive Assessment (MoCA) score \< 26);
  • a history of another neurologic disease;
  • anesthesia of joint position sense in upper limbs;
  • are pregnant or have a chance that they might be (self-reported);

Exclusion

    Key Trial Info

    Start Date :

    September 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2029

    Estimated Enrollment :

    74 Patients enrolled

    Trial Details

    Trial ID

    NCT06523335

    Start Date

    September 1 2024

    End Date

    September 1 2029

    Last Update

    July 26 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Houston

    Houston, Texas, United States, 77204